ArisGlobal today announced details of its annual Life Sciences Technology Summit (AGLSTS 2019), taking place October 1st – 3rd at the Miami Beach EDITION hotel in Miami Beach, Florida. The 3-day event will bring together senior executives, IT and business practitioners, and industry experts across drug safety, regulatory affairs, clinical development, and medical affairs to discuss how a unified platform and automation technology can transform the drug development process.

ArisGlobal, LLC, a leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, will present a session titled “How to Fully Leverage Automation in PV – A Real Case Study” at the upcoming World Drug Safety Congress Europe 2019, September 10-11, 2019 at the Hotel Hilton Amsterdam, Amsterdam, Netherlands.

Nordic Capital, a leading private equity investor with deep experience in healthcare and technology has entered into a definitive agreement to acquire ArisGlobal.

Miami, Florida – May 2, 2019 – ArisGlobal, LLC, a ...

ArisGlobal, LLC, a leading provider of life sciences software will present a session titled “Are You Ready for the New Era in PV?” at the upcoming World Drug Safety Congress Americas 2019

LifeSphere Publishing is an advanced, ,multi-tenant cloud submissions management system that enables life science organizations to easily compile, publish, and validate regulatory submissions with full support for all major global eCTD requirements

LifeSphere EasyDocs is a highly configurable, advanced cloud platform architected to streamline and unify enterprise document management and provide continuity of cross-functional workflows across the full drug development process

ArisGlobal Safety Experts to Present “Supporting Life Science Industry to Meet the New Regulation Challenges” at 9th Asia Pharma R&D Leaders – Pharma & Healthcare

ArisGlobal, a leading life sciences technology provider, announced that China-based Fosun Pharma has selected LifeSphere Safety MultiVigilance (LSMV) as its global pharmacovigilance system.